Mark Hlatky, MD

Publication Details

  • Economic Endpoints in clinical trials EPIDEMIOLOGIC REVIEWS Hlatky, M. A. 2002; 24 (1): 80-84


    Economic endpoints are increasingly common in randomized clinical trials. As a relatively new addition to the field, methods of measuring and analyzing cost data are still evolving. These developments will be stimulated by the demands of the public for efficient and effective medical care, which will be based on the findings of clinical trials.

    View details for Web of Science ID 000176581000010

    View details for PubMedID 12119860

Stanford Medicine Resources:

Footer Links: